公开(公告)号：US08178548B2

公开(公告)日：2012-05-15

申请号：US12212315

申请日：2008-09-17

申请人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G. Z. Zhang

发明人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G. Z. Zhang

IPC分类号： A61K31/505 ,  C07D239/02 ,  C07D401/00

CPC分类号： C07D239/22 ,  A61K31/513 ,  C07D239/54 ,  C07D239/553 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

公开(公告)号：US08986740B2

公开(公告)日：2015-03-24

申请号：US13441528

申请日：2012-04-06

申请人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G. Z. Zhang

发明人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G. Z. Zhang

IPC分类号： A61K9/14 ,  A61K31/505 ,  C07D239/22 ,  C07D239/54 ,  C07D239/553 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10

CPC分类号： C07D239/22 ,  A61K31/513 ,  C07D239/54 ,  C07D239/553 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

公开(公告)号：US20090176784A1

公开(公告)日：2009-07-09

申请号：US12212315

申请日：2008-09-17

申请人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G.Z. Zhang

发明人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G.Z. Zhang

IPC分类号： A61K31/5377 ,  C07D239/22 ,  A61K31/513 ,  C07D401/10 ,  C07D413/10 ,  C12N7/06

CPC分类号： C07D239/22 ,  A61K31/513 ,  C07D239/54 ,  C07D239/553 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

摘要翻译： 本发明涉及：（a）特别是抑制HCV的化合物及其盐; （b）可用于制备这些化合物和盐的中间体; （c）包含这些化合物和盐的组合物; （d）制备这种中间体，化合物，盐和组合物的方法; （e）使用这些化合物，盐和组合物的方法; 和（f）包含这些化合物，盐和组合物的试剂盒。

公开(公告)号：US20120189580A1

公开(公告)日：2012-07-26

申请号：US13441528

申请日：2012-04-06

申请人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G.Z. Zhang

发明人： Pamela L. Donner ,  John T. Randolph ,  Allan C. Krueger ,  David A. Betebenner ,  Douglas K. Hutchinson ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  John K. Pratt ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  John E. Hengeveld ,  Rodger F. Henry ,  Xiaochun Lou ,  Geoff G.Z. Zhang

IPC分类号： A61K31/513 ,  C12N7/06 ,  A61K31/7056 ,  A61P31/14 ,  C07D239/54 ,  A61K38/21

CPC分类号： C07D239/22 ,  A61K31/513 ,  C07D239/54 ,  C07D239/553 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

公开(公告)号：US08501238B2

公开(公告)日：2013-08-06

申请号：US13451889

申请日：2012-04-20

申请人： Charles A. Flentge ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G. Z. Zhang

发明人： Charles A. Flentge ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G. Z. Zhang

IPC分类号： A61K9/14 ,  A61K31/505 ,  C07D239/02 ,  C07D401/00

CPC分类号： C07D239/54 ,  A61K31/513 ,  A61K45/06 ,  C07D239/22 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10 ,  A61K2300/00

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

公开(公告)号：US08188104B2

公开(公告)日：2012-05-29

申请号：US12212323

申请日：2008-09-17

申请人： Charles A. Flengte ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G. Z. Zhang

发明人： Charles A. Flengte ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G. Z. Zhang

IPC分类号： A61K31/505 ,  C07D401/00 ,  C07D239/02

CPC分类号： C07D239/54 ,  A61K31/513 ,  A61K45/06 ,  C07D239/22 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10 ,  A61K2300/00

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

摘要翻译： 本发明涉及：（a）特别是抑制HCV的化合物及其盐; （b）可用于制备这些化合物和盐的中间体; （c）包含这些化合物和盐的组合物; （d）制备这种中间体，化合物，盐和组合物的方法; （e）使用这些化合物，盐和组合物的方法; 和（f）包含这些化合物，盐和组合物的试剂盒。

公开(公告)号：US20090186912A1

公开(公告)日：2009-07-23

申请号：US12212323

申请日：2008-09-17

申请人： Charles A. Flengte ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G.Z. Zhang

发明人： Charles A. Flengte ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G.Z. Zhang

IPC分类号： A61K31/513 ,  C07D239/10 ,  C07D401/10 ,  A61K31/506 ,  A61P31/12

CPC分类号： C07D239/54 ,  A61K31/513 ,  A61K45/06 ,  C07D239/22 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10 ,  A61K2300/00

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

公开(公告)号：US20120244119A1

公开(公告)日：2012-09-27

申请号：US13451889

申请日：2012-04-20

申请人： Charles A. Flentge ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G.Z. Zhang

发明人： Charles A. Flentge ,  Douglas K. Hutchinson ,  David A. Betebenner ,  David A. DeGoey ,  Pamela L. Donner ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Yaya Liu ,  Kenton L. Longenecker ,  Clarence J. Maring ,  Christopher E. Motter ,  John K. Pratt ,  John T. Randolph ,  Todd W. Rockway ,  Kent D. Stewart ,  Rolf Wagner ,  Shuang Chen ,  Yi Gao ,  Xiaochun Lou ,  Geoff G.Z. Zhang

IPC分类号： C07D239/54 ,  A61K38/21 ,  A61P31/14 ,  A61K31/513

CPC分类号： C07D239/54 ,  A61K31/513 ,  A61K45/06 ,  C07D239/22 ,  C07D401/10 ,  C07D403/10 ,  C07D405/10 ,  C07D409/10 ,  C07D413/10 ,  C07D417/10 ,  A61K2300/00

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

摘要翻译： 本发明涉及：（a）特别是抑制HCV的化合物及其盐; （b）可用于制备这些化合物和盐的中间体; （c）包含这些化合物和盐的组合物; （d）制备这种中间体，化合物，盐和组合物的方法; （e）使用这些化合物，盐和组合物的方法; 和（f）包含这些化合物，盐和组合物的试剂盒。

公开(公告)号：US08741914B2

公开(公告)日：2014-06-03

申请号：US13260206

申请日：2010-03-25

申请人： Todd W. Rockway ,  David A. Betebenner ,  David A. DeGoey ,  Charles A. Flentge ,  Douglas K. Hutchinson ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Kenton L. Longenecker ,  John K. Pratt ,  Kent D. Stewart ,  Rolf Wagner ,  Clarence J. Maring

发明人： Todd W. Rockway ,  David A. Betebenner ,  David A. DeGoey ,  Charles A. Flentge ,  Douglas K. Hutchinson ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Kenton L. Longenecker ,  John K. Pratt ,  Kent D. Stewart ,  Rolf Wagner ,  Clarence J. Maring

IPC分类号： C07D401/04 ,  C07D403/04 ,  A61K31/513

CPC分类号： C07D401/04 ,  C07D403/04 ,  C07D407/04 ,  C07D409/14

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

摘要翻译： 本发明涉及：（a）特别是抑制HCV的化合物及其盐; （b）可用于制备这些化合物和盐的中间体; （c）包含这些化合物和盐的组合物; （d）制备这种中间体，化合物，盐和组合物的方法; （e）使用这些化合物，盐和组合物的方法; 和（f）包含这些化合物，盐和组合物的试剂盒。

公开(公告)号：US20120100104A1

公开(公告)日：2012-04-26

申请号：US13260206

申请日：2010-03-25

申请人： Todd W. Rockway ,  David A. Betebenner ,  David A. DeGoey ,  Charles A. Flentge ,  Douglas K. Hutchinson ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Kenton L. Longenecker ,  John K. Pratt ,  Kent D. Stewart ,  Rolf Wagner ,  Clarence J. Maring

发明人： Todd W. Rockway ,  David A. Betebenner ,  David A. DeGoey ,  Charles A. Flentge ,  Douglas K. Hutchinson ,  Warren M. Kati ,  Allan C. Krueger ,  Dachun Liu ,  Kenton L. Longenecker ,  John K. Pratt ,  Kent D. Stewart ,  Rolf Wagner ,  Clarence J. Maring

IPC分类号： A61K31/506 ,  C07D403/10 ,  C07D409/14 ,  A61P31/14 ,  A61K31/7056 ,  A61K38/21 ,  C12N7/06 ,  C07D401/10 ,  A61K31/517

CPC分类号： C07D401/04 ,  C07D403/04 ,  C07D407/04 ,  C07D409/14

摘要： This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.